| Document |
Document Title |
|
WO/2024/089216A1 |
Compounds of formula (I) wherein the substituents are as defined in claim 1, and the agrochemically acceptable salts, stereoisomers, enantiomers, tautomers and N-oxides of those compounds, can be used as insecticides.
|
|
WO/2024/090485A1 |
The present invention provides a method for producing a fluorine-containing compound under relatively mild conditions by introducing a fluorine atom into a wide variety of oxygen-containing compounds having a ketone group, an aldehyde gr...
|
|
WO/2024/085386A1 |
It has been identified that an alkynyl amino acid ester derivative preparation method using a photocatalytic reaction, according to the present invention, is simple and enables a linear, cyclic or chiral alkynyl amino acid ester derivati...
|
|
WO/2024/085607A1 |
The present invention provides a novel compound and an organic light-emitting device using same.
|
|
WO/2024/085208A1 |
This compound is a compound represented by formula (1). [In the formula, n represents an integer from 1-3. L1 represents a possibly branched, (n + 1)-valent linking group (but excluding chain saturated aliphatic hydrocarbon groups). ...
|
|
WO/2024/085354A1 |
The present invention provides, in the present specification, a heterocyclic compound and an organic light-emitting device including same.
|
|
WO/2024/084186A1 |
The presentation invention relates to compounds of formula (I) and pharmaceutical compositions thereof. The compounds may be used to treat an infection, such as a parasitic infection or a bacterial infection. In some embodiments, the com...
|
|
WO/2024/079734A1 |
The invention relates to a method for preparing 4-alkoxy carbonyl-3 -aminothiophene of formula (I) or acid- addition salt thereof of formula (I)', which comprises reacting the corresponding 3 -oxotetrahydrothiophenes compound of formula ...
|
|
WO/2024/080128A1 |
The present invention addresses the problem of providing an actinic ray-sensitive or radiation-sensitive resin composition from which a resist pattern having a small LWR can be formed. An actinic ray-sensitive or radiation-sensitive resi...
|
|
WO/2024/078137A1 |
An organic electroluminescent device and an electronic apparatus. The organic electroluminescent device comprises a cathode, an anode, and an organic layer, the organic layer comprises an organic light-emitting layer, and the organic lig...
|
|
WO/2024/081714A2 |
Disclosed herein are new inhibitors of GroEL/ES and HSP60/10 chaperonin systems that serve as new antibiotic candidates against a variety of infectious organisms. The identified compounds can selectively kill Escherichia coli, the ESKAPE...
|
|
WO/2024/076117A1 |
The present invention is an organic compound used in an organic layer provided in an organic light-emitting element. In particular, when the organic compound is used in an electron blocking layer of an organic light-emitting element, it ...
|
|
WO/2024/075537A1 |
The present invention addresses the problem of providing a reactive compound having excellent storage stability. The present invention relates to a reactive compound represented by formula (1). (In formula (1), Ar1 denotes an aromatic ...
|
|
WO/2024/071281A1 |
The purpose of the present invention is to provide: a novel asymmetric fluorinated allyl compound that can be induced to various bioactive medium-sized molecules, and that has high optical purity; and a method for producing the same. Asy...
|
|
WO/2024/067560A1 |
Disclosed in the present invention are a sulfonamide compound and the medical use thereof as a STING inhibitor, specifically, a compound as represented by formula (I) or a pharmaceutically acceptable salt or ester or solvate thereof, whi...
|
|
WO/2024/071771A1 |
The present invention provides: a novel compound capable of improving the light-emitting efficiency, stability and lifespan of an element; an organic electrical element using same; and an electronic device thereof.
|
|
WO/2024/071770A1 |
The present invention provides: a novel compound capable of improving the light-emitting efficiency, stability and lifespan of an element; an organic electrical element using same; and an electronic device thereof.
|
|
WO/2024/071250A1 |
This diamondoid compound is a new compound represented by general formula (1) [in the formula, ring A1 represents an aliphatic ring having two or more rings, R1 represents a hydrogen atom, an alkyl group, a cycloalkyl group, or an adaman...
|
|
WO/2024/059951A1 |
This invention provides compound having a structure of Formulas I-VI. Uses of such compounds for treatment of various indications that would benefit from modulation of the androgen receptor, including prostate cancer. Also provided are m...
|
|
WO/2024/059659A1 |
Provided herein are compounds of formula (I): or a stereoisomer or tautomer thereof, or a pharmaceutically acceptable salt of any of the foregoing, wherein m, n, Y1, Y2, X1, X2, X3, Q1, and Ra are as defined elsewhere herein. Also provid...
|
|
WO/2024/057020A1 |
This invention relates to compounds that can be used to treat viral infections. The compounds are papain-like protease (PLpro) inhibitors.
|
|
WO/2024/055658A1 |
The present invention belongs to the technical field of organic materials, and provides a nitrogen-containing compound, an electronic element, and an electronic device. The structure of the nitrogen-containing compound is represented by ...
|
|
WO/2024/058075A1 |
The present invention employs a resist composition that contains: a base material component, the solubility of which in a developer solution is changed by the action of an acid; and a compound which is represented by general formula (d0)...
|
|
WO/2024/052910A1 |
The invention relates to a method for the preparation of preparing N-(l-methoxyprop-2-yl)-2,4- dimethyl-3-aminothiophene or salts thereof comprising contacting 2,4-dimethyl-2,3- dihydrothiophen-3-one with 2-methoxyisopropylamine, in the ...
|
|
WO/2024/049017A1 |
The present invention relates to an organic semiconductor compound with high transmittance in the visible light spectrum and a use thereof.
|
|
WO/2024/046253A1 |
Provided in the present invention are a sodium channel regulator and the use thereof. The sodium channel regulator of the present invention has a brand-new structure and has an excellent in-vitro inhibitory effect on Nav 1.8. The compoun...
|
|
WO/2024/043334A1 |
The present invention addresses the problem of providing a compound and pharmaceutical composition that possesses inhibitory activity against the drug efflux pumps of drug-resistant bacteria and, when used in combination with another dru...
|
|
WO/2024/040995A1 |
The present application relates to a synthesis method for an N-methyl-3-substituted methyl-4-pyrazolecarboxamide derivative and N-methyl-3-substituted methyl-4-pyrazolecarboxylic acid, the method comprising the following steps: S1: synth...
|
|
WO/2024/043098A1 |
The present invention employs a resist composition containing: a base material component of which the solubility in a developing solution changes due to the action of an acid; and a compound represented by general formula (d0). In formul...
|
|
WO/2024/042187A1 |
Disclosed herein are compounds of the formula (I) or a pharmaceutically acceptable salt thereof (I) Wherein R1 and R2 independently represent a hydrogen atom or a deuterium atom; R3' and R3" independently represent a hydrogen atom, a met...
|
|
WO/2024/042152A1 |
Disclosed herein are compounds of the formula (I), or pharmaceutically acceptable salts thereof, wherein R1 and R2 independently represent a hydrogen atom or a deuterium atom; R3' and R3" independently represent a hydrogen atom, a methyl...
|
|
WO/2024/043121A1 |
The present invention employs a resist composition including: a base material component, the solubility of said base material component in a developing fluid changing due to the action of an acid; and a compound represented by general fo...
|
|
WO/2024/041503A1 |
The present invention discloses compounds of formula (I) which can bind to mutant p53 and restore the ability of the p53 mutant to bind DNA and activate downstream effectors involved in tumor suppression. Also provided are processes for ...
|
|
WO/2024/039095A1 |
The present specification relates to a heterocyclic compound represented by chemical formula 1, an organic light-emitting element comprising same, and a composition for an organic layer.
|
|
WO/2024/037564A1 |
The present invention provides a compound represented by formula I, or a pharmaceutically acceptable salt thereof, or a stereoisomer thereof, or a solvate thereof, or a prodrug thereof, or a metabolite thereof, or a deuterated compound t...
|
|
WO/2024/035085A1 |
The present invention relates to a novel compound, and a composition for preventing or treating HER2-positive cancer, comprising same. The novel compound of the present invention can suppress the level of HER2 by inhibiting the protein-p...
|
|
WO/2024/026290A1 |
The present invention relates to compounds, pharmaceutically acceptable salts of the compounds, and pharmaceutical compositions of the compounds, or salts thereof, that can inhibit secreted phospholipases A2 (sPLA2-X) enzymes, wherein th...
|
|
WO/2024/025353A1 |
The present invention relates to: an organic compound employed as an organic layer material, such as an electron-blocking layer in an organic light-emitting device; and an organic light-emitting device comprising same. When the compound ...
|
|
WO/2024/019444A1 |
Provided is an organic compound contributing to improving the substantial light efficiency and field of view of an organic electroluminescent device. The organic electroluminescent device according to the present invention comprises: a f...
|
|
WO/2024/016687A1 |
The present application belongs to the field of organic light-emitting materials, and particularly relates to a nitrogen-containing compound, an electronic element and an electronic apparatus. The structure of the nitrogen-containing com...
|
|
WO/2024/017221A1 |
A synthesis method for an α-azido ketone containing a tertiary chiral center, the synthesis method comprising: under the action of a squaramide catalyst, reacting a sulfoxonium ylide derivative with an azidation reagent HN3 generated in...
|
|
WO/2024/014462A1 |
This resist composition comprises a resin component (A1) that exhibits change in solubility in a developing solution due to the action of an acid. The resin component (A1) has a constitution unit (a0) derived from a compound represented ...
|
|
WO/2024/011415A1 |
Disclosed in the present invention is a method for preparing an o-iodophenyl compound, wherein an iodobenzene compound and an amide compound as raw materials are reacted in the presence of sodium hydride or n-butyllithium and a solvent t...
|
|
WO/2023/280638A9 |
The application relates to vinyl thianthrenium compounds Vinyl- TT+X- of the Formula (I), a process for preparing the same and the use thereof for vinylating organic compounds.
|
|
WO/2024/008805A1 |
The invention relates to heteroaromatic ketones of formula (I) for radical and cationic polymerization (I), wherein the substituents A, B, C and D can be the same or different and are nitrogen or carbon, while R1 and R2, independently of...
|
|
WO/2024/003557A1 |
Described herein are compounds of formula I, or a salt or solvate, thereof formula (I). Also described are pharmaceutical compositions and combinations comprising the compounds, and their use in the treatment of conditions mediated by ly...
|
|
WO/2024/002457A1 |
A polyamide comprising monomer units containing at least one elementary unit according to formula (I), wherein R1 is a linear alkyl containing 1 to 6 carbon atoms; and wherein R2 is an aliphatic chain containing 1 to 30 carbon atoms sele...
|
|
WO/2023/250060A1 |
Alkoxy-substituted N-benzyl-2-phenylacetamide compounds and derivatives are G-protein coupled receptor (GPR) 88 modulators for use in the treatment of a disease mediated by GPR88. Indications include Tourette's Syndrome, Huntington's Dis...
|
|
WO/2023/250467A2 |
In one aspect, the present disclosure relates to compounds which inhibit one or more β-lactamases and/or penicillin binding proteins (PBPs), and pharmaceutical compositions thereof. In another aspect, the present disclosure provides a m...
|
|
WO/2023/246836A1 |
The present application relates to the technical field of biological medicines, and in particular relates to a novel five-membered heterocycle substituted styrene derivative, and a preparation method therefor and the use thereof. The sty...
|
